Cargando…
Nonsuppressible viremia during HIV-1 therapy meets molecular virology
HIV-1 replication can be suppressed with antiretroviral therapy (ART), but individuals who stop taking ART soon become viremic again. Some people experience extended times of detectable viremia despite optimal adherence to ART. In this issue of the JCI, White, Wu, and coauthors elucidate a source of...
Autores principales: | Emery, Ann, Joseph, Sarah B., Swanstrom, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014097/ https://www.ncbi.nlm.nih.gov/pubmed/36919694 http://dx.doi.org/10.1172/JCI167925 |
Ejemplares similares
-
Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia
por: White, Jennifer A., et al.
Publicado: (2023) -
HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
por: Kemp, Steven A., et al.
Publicado: (2022) -
Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study
por: Kauma, Geraldine, et al.
Publicado: (2023) -
Cryptococcal Antigen Screening Among Antiretroviral Therapy–Experienced People With HIV With Viral Load Nonsuppression in Rural Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2021) -
HIV-1: To Splice or Not to Splice, That Is the Question
por: Emery, Ann, et al.
Publicado: (2021)